Successful Long-Term Treatment with Linezolid for Disseminated Infection with Multiresistant Nocardia farcinica

Peleg AY, Husain S, Qureshi ZA, Silveira FP, Sarumi M and Shutt KA, et al. (2007). Risk factors, clinical characteristics, and outcome of Nocardia infection in organ transplant recipients: a matched case–control study. Clin Infect Dis 44: 1307–1314

Munoz J, Mirelis B, Aragon LM, Gutierrez N, Sanchez F and Espanol M, et al. (2007). Clinical and microbiological features of nocardiosis 1997–2003. J Med Microbiol 56: 545–550

Biehle JR, Cavallieri JR, Saubolle MA and Getsinger LJ (1994). Comparative evaluation of the Etest for susceptibility testing of Nocardia species. Diagn Microbiol Infect Dis 19: 101–110

Ambaye AP, Kohner C, Wollan PC, Roberts KL, Roberts GD and Cockerill FR (1997). Comparison of agar dilution, broth microdilution, disk diffusion, E-test, and BACTEC radiometric methods for antimicrobial susceptibility testing of Nocardia asteroides complex. J Clin Microbiol 35: 847–852

Dorman SE, Guide SV, Conville PS, DeCarlo ES, Malech HL and Gallin JI (2002). Nocardia infection in chronic granulomatous disease. Clin Infect Dis 35: 390–394

Parmentier L, Salmon-Ceron D, Boiron P, Paul G, Guez T and Dupont B, et al. (1992). Pneumopathy and kidney abscess due to Nocardia farcinica in an HIV-infected patient. AIDS 6: 891–893

Nampoory MRN, Khan ZU, Johny KV, Nessim J, Gupta RK and Al-Muzairai I (1996). Nocardiosis in renal transplant recipients in Kuwait. Nephrol Dial Transplant 11: 1134–1138

Minamoto GY and Sordillo EM (1998). Disseminated nocardiosis in a patient with AIDS: diagnosis by blood and cerebrospinal fluid cultures. Clin Infect Dis 26: 242–243

Miksits K, Stoltenburg G, Neumayer HH, Spiegel H, Schaal KP and Cervos-Navarro J, et al. (1991). Disseminated infection of the central nervous system caused by Nocardia farcinica. Nephrol Dial Transplant 6: 209–214

Lewis DE, Ebden P, Wooster SL, Rees J and Harrison GA (2003). Multi-system infection with Nocardia farcinica-therapy with linezolid and minocycline. J Infect 46: 199–202

Moylett EH, Pacheco SE, Brown-Elliott BA, Perry TR, Buescher S and Birmingham MC (2003). Clinical experience with linezolid for the treatment of Nocardia infection. Clin Infect Dis 36: 313–318

Soriano A, Gomez J, Gomez L, Azanza JR, Perez R and Romero F, et al. (2007). Efficacy and tolerability of prolonged linezolid therapy in the treatment of orthopedic implant infections. Eur J Clin Microbiol Infect Dis 26: 353–356

Senneville E, Legout L, Valette M, Yazdanpanah Y, Beltrand E, Caillaux M, Migaud H and Mouton Y (2006). Effectiveness and tolerability of prolonged linezolid treatment for chronic osteomyelitis: a retrospective study. Clin Ther 28: 1155–1163

Fortun J, Martin-Davila P, Navas E, Perez-Elias MJ, Cobo J and Tato M, et al. (2005). Linezolid for the treatment of multidrug-resistant tuberculosis. J Antimicrob Chemother 56: 180–185

Senneville E, Legout L, Valette M, Yazdanpanah Y, Giraud F, Beltrand E, Obert G, Dubreuil L, Migaud H and Mouton Y (2004). Risk factors for anaemia in patients on prolonged linezolid therapy for chronic osteomyelitis: a case–control study. J Antimicrob Chemother 54: 798–802

Plachouras D, Giannitsioti E, Athanassia S, Kontopidou F, Papadopoulos A, Kanellakopoulou K and Giamarellou H (2006). No effect of pyridoxine on the incidence of myelosuppression during prolonged linezolid treatment. Clin Infect Dis 43: e89–e91

Bernstein WB, Trotta RF, Rector JT, Tjaden JA and Barile AJ (2003). Mechanisms for linezolid-induced anemia and thrombocytopenia. Ann Pharmacother 37: 517–520

Lewis KE, Ebden P, Wooster SL, Rees J and Harrison GA (2003). Multi-system infection with Nocardia farcinica-therapy with linezolid and minocycline. J Infect 46: 199–202

Spellberg B, Yoo T and Bayer AS (2004). Reversal of linezolid-associated cytopaenias, but not peripheral neuropathy, by administration of vitamin B6. J Antimicrob Chemother 54: 832–835

McKinley SH and Foroozan R (2005). Optic neuropathy associated with linezolid treatment. J Neuroophthalmol 25: 18–21

Bressler AM, Zimmer SM, Gilmore JL and Somani J (2004). Peripheral neuropathy associated with prolonged use of linezolid. Lancet Infect Dis 4: 528–531

Ferry T, Ponceau B, Simon M, Issartel B, Petiot P and Boibieux A (2005). Possibly linezolid-induced peripheral and central neurotoxicity: report of four cases. Infection 33: 151–154